900120 — CXI Healthcare Technology Share Price
0.000.00%
Last trade - 00:00- KR₩33bn
- -KR₩99bn
- CNY377.03m
- 49
- 100
- 26
- 64
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.07 | ||
| Price to Tang. Book | 0.07 | ||
| Price to Free Cashflow | 0.75 | ||
| Price to Sales | 0.46 | ||
| EV to EBITDA | -2.38 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.76% | ||
| Return on Equity | 4.03% | ||
| Operating Margin | 24.48% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 777.84 | 373.11 | 609.73 | 545.21 | 377.03 | n/a | n/a | -15.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +5.01 | -11.09 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CKH Food & Health Limited is a Cayman Islands-based health food manufacturing and distribution company. The Company is engaged in the production of health supplements, functional health foods, and tea products. The Company is specialized in the production of various types of products such as tablets, capsules, granules, drinks, and tea. The Company’s products include traditional Chinese medicine-based dietary supplements (capsules/tablets/drinks/tea). The Company’s products include Kimparis Ellabie HA Waterful Sunscreen, Kimparis Ellabie PDR Serum, Pterygium capsule, Raw Steel Capsule and more.
Directors
- Jinsheng Lin CEO (51)
- Yan Liu OTH (27)
- Haibing Dai DRC (41)
- Yueren Wang DRC (49)
- John Yang DRC (46)
- Yi Huang NID (49)
- Byeong Jae Kim NID (53)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 1970
- Public Since
- March 31st, 2010
- No. of Employees
- 257
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 288,232,166
- Address
- Third Floor, GEORGE TOWN, KY1-1103
- Web
- http://www.ckhfnh.co.kr/company/summary
- Phone
- +null 59188031033
- Auditors
- Shinhan Accounting Corporation
Upcoming Events for 900120
CKH Food & Health Ltd Annual Shareholders Meeting
Similar to 900120
Asia Seed Co
Korea Exchange - KOSDAQ
Bifido Co
Korea Exchange - KOSDAQ
BL PharmTech
Korea Exchange - KOSDAQ
ByOn Co
Korea Exchange - KOSDAQ
CanariaBio
Korea Exchange - KOSDAQ
FAQ
What is the CXI Healthcare Technology share price?
As of Today at 19:06 UTC, shares in CXI Healthcare Technology are trading at KR₩113. This share price information is delayed by 15 minutes.
How has the CXI Healthcare Technology share price performed this year?
Shares in CXI Healthcare Technology last closed at KR₩113 and the price had moved by -38.59% over the past 365 days. In terms of relative price strength the CXI Healthcare Technology share price has underperformed the FTSE Developed Asia Pacific Index by -35.9% over the past year.
What are the analyst and broker recommendations for CXI Healthcare Technology?
There is no consensus recommendation for this security.
What is the CXI Healthcare Technology dividend yield?
CXI Healthcare Technology does not currently pay a dividend.
Does CXI Healthcare Technology pay a dividend?
CXI Healthcare Technology does not currently pay a dividend.
When does CXI Healthcare Technology next pay dividends?
CXI Healthcare Technology does not currently pay a dividend.
How do I buy CXI Healthcare Technology shares?
To buy shares in CXI Healthcare Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CXI Healthcare Technology?
As of the previous close price of KR₩113, shares in CXI Healthcare Technology had a market capitalisation of KR₩33bn.
Where are CXI Healthcare Technology shares listed?
Here are the trading details for CXI Healthcare Technology:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 900120
What kind of share is CXI Healthcare Technology?
Based on an overall assessment of its quality, value and momentum CXI Healthcare Technology is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CXI Healthcare Technology share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the CXI Healthcare Technology share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CXI Healthcare Technology. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.31%.
As of the last closing price of KR₩113, shares in CXI Healthcare Technology were trading -9.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CXI Healthcare Technology PE Ratio?
The CXI Healthcare Technology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩113.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CXI Healthcare Technology?
CXI Healthcare Technology's management team is headed by:
- Jinsheng Lin - CEO
- Yan Liu - OTH
- Haibing Dai - DRC
- Yueren Wang - DRC
- John Yang - DRC
- Yi Huang - NID
- Byeong Jae Kim - NID